Pay in 4 interest-free payments of $6.67 Learn more
Ships within 48 hours · Estimated delivery Nov 4 - Nov 9
10.1007/s00429-014-0714-z Summary Keywords GLP-1, obesity, diabetes, CNS, insulin Citation Heppner KM and Perez-Tilve D (2015) GLP-1 based therapeutics: simultaneously combating T2DM and obesity
Ethics declarations Conflict of interest KK has received lecture fees from Otsuka Pharmaceutical and Novartis
GLP-1s are one of the most powerful tools in modern medicine offering benefits that may extend beyond weight loss to better metabolic health, cardiovascular function, and inflammation reduction
Zulassung fr Diabetes Typ 2 Bei Menschen mit Typ-2-Diabetes ist der Blutzuckerspiegel dauerhaft erhht, weil die Krperzellen den Blutzucker (Glukose) nicht mehr ausreichend aufnehmen
Bigdeli H, Snyder PJ
US$ 23.28
US$ 27.10
US$ 25.48
US$ 22.31
